$67.59
+0.03 (+0.04%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+39.22%
YTD
+9.49%
Open$68.07
Previous Close$67.56
Day High$69.56
Day Low$67.48
52W High$88.31
52W Low$47.22
Volume—
Avg Volume1.70M
Market Cap9.65B
P/E Ratio—
EPS$-7.22
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$63.59
Above
SMA 200
$49.97
Above
RSI (14)
55.5
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
28 analysts
Price Target
+18.1% upside
Current
$67.59
$67.59
Target
$79.81
$79.81
$53.35
$79.81 avg
$115.71
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 102.81M | 105.30M | 617.31M |
| Net Income | -916,673,735 | -845,033,659 | 113.32M |
| Profit Margin | -891.6% | -847.0% | 18.4% |
| EBITDA | -844,764,280 | -822,007,647 | 314.99M |
| Free Cash Flow | — | — | 143.60M |
| Rev Growth | -2.4% | -2.4% | +3.9% |
| Debt/Equity | 0.59 | 0.59 | 0.20 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $265.21 | +0.28% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $410.24 | +4.34% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $152.67 | +1.40% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $514.99 | +0.84% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $803.90 | +0.72% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $251.65 | +3.00% | 40.0 | 32.33B |